Xiaobo Sun

Title: Innovations of Xiaobo Sun in Pharmaceutical Applications

Introduction

Xiaobo Sun is a prominent inventor based in Beijing, China. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds aimed at treating cardiovascular and cerebrovascular diseases. With a total of 2 patents, his work showcases innovative approaches to enhancing drug efficacy.

Latest Patents

Xiaobo Sun's latest patents include a hydroxypentyl benzoic acid diester compound and its preparation method and pharmaceutical application. This invention focuses on improving the concentration of butylphthalide in cerebral vessels, utilizing dexborneol to enhance the drug's ability to penetrate the blood-brain barrier. The compound demonstrates a multi-target, multi-channel synergistic brain protection effect, particularly in treating cerebral ischemia. Additionally, he has developed a combination of Radix et Rhizoma Notoginseng and aspirin, which aims to prevent and treat cardiovascular and cerebrovascular diseases while minimizing gastric mucosal damage caused by aspirin.

Career Highlights

Xiaobo Sun is affiliated with the Chinese Academy of Medical Sciences, where he conducts research and development in the pharmaceutical sector. His innovative work has positioned him as a key figure in the advancement of medical treatments.

Collaborations

Xiaobo has collaborated with notable colleagues, including Xiangbao Meng and Guibo Sun, to further enhance the impact of his research and inventions.

Conclusion

Xiaobo Sun's contributions to pharmaceutical innovations reflect his commitment to improving healthcare outcomes. His patents not only demonstrate his inventive capabilities but also highlight the potential for significant advancements in medical treatments.